PLSE - I listened to the last CC but haven't paid attention since. I recall from the CC that there was still a lack of clarity on what the FDA required for cancer procedures other than that they can't just apply for general soft tissue procedures and then have it used off label for cancers. What will the data be regarding? TIA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.